- Home
- DGICA vs HQL Comparison
DGICA vs HQL Comparison
Compare DGICA & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | DGICA | HQL |
|---|---|---|
| Founded | 1986 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 714.2M | 689.4M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | DGICA | HQL |
|---|---|---|
| Price | $18.06 | $18.20 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | 89.5K | ★ 114.6K |
| Earning Date | 10-29-2026 | 01-01-0001 |
| Dividend Yield | 4.33% | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $978,014,322.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $7.82 | $24.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.11 | $15.60 |
| 52 Week High | $21.06 | $22.67 |
Technical Indicators
Market Signals| Indicator | DGICA | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 33.86 | 34.00 |
| Support Level | $16.43 | $16.06 |
| Resistance Level | $19.54 | $20.20 |
| Average True Range (ATR) | 0.41 | 0.48 |
| MACD | -0.11 | -0.10 |
| Stochastic Oscillator | 10.34 | 16.47 |
Price Performance
Historical ComparisonAbout DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.